The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Koppel Adam since year 2005.
The trader's CIK number is 1578965.
At the time of this reporting, Koppel Adam is the Director of Replimune Group, Inc. .
(stock ticker symbol REPL).
See this page for all insider trading activities at Replimune Group, Inc. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2018-07-24||REPL||Replimune Group, Inc.||Buy||500,000||15.00||7,500,000|
|2018-01-30||SLDB||Solid Biosciences Inc.||Buy||300,000||16.00||4,800,000|
|2018-01-25||SLDB||Solid Biosciences Inc.||Option Ex||1,689,444||.00||0|
|2017-12-15||MRNS||Marinus Pharmaceuticals Inc||Sale||822,547||8.33||6,849,348|
|2017-12-18||MRNS||Marinus Pharmaceuticals Inc||Sale||300,000||7.50||2,251,500|
|2017-12-19||MRNS||Marinus Pharmaceuticals Inc||Sale||150,000||7.36||1,104,450|
|2017-12-18||DRNA||Dicerna Pharmaceuticals Inc||Buy||285,000||7.00||1,995,000|
|2017-12-18||DRNA||Dicerna Pharmaceuticals Inc||Option Ex||8,454,388||.00||0|
|2016-06-02||BIIB||Biogen Inc.||Option Ex||1,643||.00||0|
|2015-06-02||BIIB||Biogen Inc.||Option Ex||2,384||.00||0|
|2013-06-25||PTCT||Ptc Therapeutics, Inc.||Buy||1,250,000||15.00||18,750,000|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Koppel Adam (Director of Replimune Group, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.